Pharmaceuticals
Company Overview of Tolerx, Inc.
Executive Profile
Peter A. Gottlieb M.D.Member of Scientific Advisory Board, Tolerx, Inc. |
| Age | Total Calculated Compensation | This person is connected to 1 Board Members in 1 different organizations across 1 different industries. See Board Relationships |
| -- | -- |
Background
Dr. Peter A. Gottlieb, MD is a Professor of Pediatrics and Medicine at the University of Colorado Denver. Dr. Gottlieb is the center director for Type 1 Diabetes TrialNet at the Barbara Davis Center for Childhood Diabetes and a member of the Immune Tolerance Network. He has been a Member of Scientific Advisory Board at Tolerx, Inc. since November 2, 2010. His clinical research focuses on the design and implementation of immune intervention trials to alter or prevent ...
Corporate Headquarters300 Technology SquareCambridge, Massachusetts 02139 United States Phone: 617-452-1300 Fax: 617-354-8300 Board Members MembershipsThere is no Board Members Memberships data available.EducationThere is no Education data available.Other AffiliationsThere is no Company Affiliations data available. |
Annual CompensationThere is no Annual Compensation data available.Stocks OptionsThere is no Stock Options data available.Total CompensationThere is no Total Compensation data available. |
COMPETITOR COMPENSATION
| There is no Competitor Compensation data available. |
Post a JobJobs
- Greenville, NC | Vidant Medical CenterPosted: May 15
- Riverside, CA | RecruitarrowPosted: May 22
- Souderton, PA | Hire IT PeoplePosted: May 22
- Cambridge, MA | RandstadPosted: May 22
Sponsored Financial Commentaries
Sponsored Links
To contact Tolerx, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.







